Literature DB >> 16128962

Written in response to Scott LD: treating hepatitis C in active injection drug users.

Brian R Edlin, Michael R Carden.   

Abstract

Mesh：

Year:  2005        PMID： 16128962      PMCID： PMC1510900          DOI： 10.1111/j.1572-0241.2005.50395_5.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  7 in total

1.  Treatment of hepatitis C in injection drug users.

Authors:  Larry D Scott
Journal:  Am J Gastroenterol       Date:  2005-01       Impact factor: 10.864

Review 2.  Prevention and treatment of hepatitis C in injection drug users.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 3.  Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Authors:  Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

4.  Two successive hepatitis C virus infections in an intravenous drug user.

Authors:  B Proust; F Dubois; Y Bacq; S Le Pogam; S Rogez; R Levillain; A Goudeau
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

5.  Syringe prescription to prevent HIV infection in Rhode Island: a case study.

Authors:  J D Rich; G E Macalino; M McKenzie; L E Taylor; S Burris
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

Review 6.  Consensus statement on office-based treatment of opioid dependence using buprenorphine.

Authors:  David A Fiellin; Herbert Kleber; Jeanne G Trumble-Hejduk; A Thomas McLellan; Thomas R Kosten
Journal:  J Subst Abuse Treat       Date:  2004-09

7.  Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users.

Authors:  Markus Backmund; Kirsten Meyer; Brian R Edlin
Journal:  Clin Infect Dis       Date:  2004-10-26       Impact factor: 9.079
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.